FDA Label and Packaging Compliance Review

Why labels receive regulatory attention

The FDA treats product labeling — including outer packaging, inserts, and many on-product claims — as part of how a product is defined in commerce. A dietary supplement label with impermissible disease claims can cause the product to be deemed an unapproved new drug. A cosmetic label implying therapeutic benefit may trigger drug misbranding analysis. Foods with unauthorized health claims face similar challenges.

Labeling violations appear frequently in FDA warning letters because labels are durable, standardized, and easy for inspectors to compare against regulatory requirements. Fixing a label error after a print run is expensive; review before production is almost always cheaper.

Imported products face additional scrutiny at U.S. entry. Labels that comply with home-country rules may still violate FDA requirements. Domestic brands expanding to club, specialty, or international retail should confirm that label claims match what those channels permit.

Product-category considerations

Dietary supplements

Supplement labels must comply with FDA formatting rules for the Supplement Facts panel, ingredient declarations, allergen statements, and structure/function claims. Structure/function claims require notification to the FDA and the standard disclaimer that the product is not intended to diagnose, treat, cure, or prevent disease. The FDA provides resources on dietary supplement labeling that form the baseline for review.

Cosmetics

Cosmetic labeling must include an identity statement, net quantity, ingredient listing, and responsible party information. Claims on cosmetic labels must not transform the product into a drug — language about changing skin structure, treating acne, or reversing disease crosses a well-lit boundary. The FDA's cosmetic labeling resources describe required label elements and common misbranding issues.

Foods

Food labels follow Nutrition Facts formatting rules, allergen labeling under FALCPA, and authorized health claim regulations. Unauthorized implied health claims on front-of-pack graphics remain a common enforcement target even when the Nutrition Facts panel itself is accurate.

The FDA also monitors whether labels mislead through suggested uses, graphic imagery, or brand names that imply unauthorized benefits. A product named or illustrated in a way that suggests disease treatment may be evaluated as a drug regardless of small-print disclaimers elsewhere on pack.

What a label review includes

• Principal display panel and information panel content and placement
• Claim language on front and back panels, including icons and symbols
• Supplement Facts, Nutrition Facts, or drug facts formatting as applicable
• Ingredient nomenclature (INCI for cosmetics, common names for foods and supplements)
• Allergen, warning, and disclaimer statements
• Consistency between label claims and website or advertising copy

Packaging beyond the label

Natascia Taken, Esq. also reviews promotional packaging — gift sets, display cartons, and insert cards — when those materials bear claims or required information. QR codes linking to non-compliant websites can extend labeling problems into digital space. Retailer-specific packaging add-ons sometimes introduce claims the core label avoided.

Common label errors Natascia Taken, Esq. catches

• Structure/function claims without the required disclaimer or FDA notification
• Drug-implying language on cosmetic principal display panels
• Incorrect order or naming of ingredients in INCI or supplement facts panels
• Unauthorized health claims or nutrient content claims on food packaging
• Missing responsible party or net quantity statements
• Claims on outer cartons that exceed what the inner label supports

Label review is a legal compliance assessment based on current FDA guidance and regulations. It does not guarantee acceptance by any particular retailer, customs authority, or the FDA in all circumstances.

Coordination with advertising and retail teams

Marketing teams sometimes request label claim changes to match campaign language — but the label often sets the ceiling for what may be said elsewhere, not the floor. Natascia Taken, Esq. works with brand and creative teams to align label updates with planned advertising launches so neither channel outpaces lawful claim boundaries.